News and Innovation

CHLA researchers uncover mechanisms driving adult membranous nephropathy, which could potentially lead to novel treatments for pediatric chronic kidney disease.

Regional and institutional variations in duration of opioid treatment for infants underscore need for national standards.

Children’s Hospital Los Angeles researchers find that most children with sickle cell anemia do not get basic preventive care.

Children’s Hospital Los Angeles research study uncovers socioeconomic factors that can impact outcomes of patients with pediatric acute liver failure (PALF).

CHLA researchers and collaborators in RECOVER Initiative published extensive review of Long COVID symptoms in children to guide physicians and families.

Children’s Hospital Los Angeles takes a team approach to cystic fibrosis care, with a focus on finding next-generation treatments.

A Children’s Hospital Los Angeles team developed the test, which is the first to precisely measure how much cerebrospinal fluid is flowing through a shunt.

The Division of Urology at Children’s Hospital Los Angeles has expanded its clinical research team, which focuses on innovative ways to improve care.

Large clinical trial to study safest and most effective pain medications for adolescents and young adults following common surgeries.

Investigators found that many MIS-C patients had cardiac abnormalities at their 6-month follow-up, so all patients treated for this condition should have a cardiac evaluation.